Keyphrases
Anticancer Drugs
100%
Cas9 Protein
33%
CRISPR-Cas9 Library
100%
CRISPR-Cas9 System
33%
Drug Resistance Gene
66%
Drug Target Discovery
33%
Dynamic Field
33%
Function Identification
33%
Gain-of-function
33%
Gene Activation
33%
Gene Inhibition
33%
Genetic Engineering Methods
33%
Genetic Screening
66%
Genome Editing
33%
Genomic Library
33%
High-throughput
33%
Library Screening
100%
Long Non-coding RNA (LncRNA)
33%
Loss Function
33%
MicroRNA
33%
Multi-omics
33%
Negative Selection
33%
Nobel Prize
33%
Non-coding RNA (ncRNA)
33%
Non-coding Sequence
33%
Omics Platforms
33%
Positive Selection
33%
Precision Medicine
33%
Screening Approach
100%
Screening Technology
33%
Small Molecule Drugs
33%
Small Molecules
33%
Target Identification
33%
Variable Application
33%
Working Principle
33%
Medicine and Dentistry
Anticarcinogen
100%
Cas9
100%
Clustered Regularly Interspaced Short Palindromic Repeat
100%
Drug Resistance
50%
Gene Activation
25%
Gene Library
50%
Genetic Engineering
25%
microRNA
25%
Personalized Medicine
25%
Promoter Region
25%
Tamsulosin
25%
Target Identification
25%
Untranslated RNA
25%
Pharmacology, Toxicology and Pharmaceutical Science
Anticarcinogen
100%
Drug Discovery
100%
Drug Resistance
66%
microRNA
33%
Tamsulosin
33%
Target Identification
33%
Untranslated RNA
33%
Immunology and Microbiology
CRISPR/Cas9
100%
Drug Resistance
50%
Gene Activation
25%
Gene Editing
25%
Gene Library
50%
Genetic Engineering
25%
Multi-Omics
25%
Promoter Region
25%